KellBenx Secures $3,211,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a422fb67-dec9-4def-9393-45e8efc1f9ba - Date
12/8/2015 - Company Name
KellBenx - Mailing Address
3500 Sunrise Highway Building 200 Great River, NY 11739 USA - Company Description
KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood. Our focus is to improve women’s healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. - Website
http://www.kellbenx.com - Transaction Type
Venture Equity - Transaction Amount
$3,211,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. - M&A Terms
- Venture Investor
Undisclosed
